Drug Profile
Propofol injectable - Avecho Biotechnology
Alternative Names: Propofol Injectable Emulsion/TPM; TPM/Propofol Injectable Emulsion; TPM®/Propofol injectableLatest Information Update: 28 May 2022
Price :
$50
*
At a glance
- Originator Phosphagenics
- Developer Avecho Biotechnology
- Class General anaesthetics; Phenols; Small molecules
- Mechanism of Action GABA A receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Anaesthesia
Most Recent Events
- 28 May 2022 No recent reports of development identified for preclinical development in Anaesthesia in Australia (Injection)
- 07 May 2020 Preclinical development is ongoing in Australia (Injection) (Phosphagenics pipeline, May 2020)
- 28 Mar 2020 No recent reports of development identified for preclinical development in Anaesthesia in Australia (Injection)